Characteristics Related to Visual Acuity Loss After Successful Photodynamic Therapy for Eyes With Central Serous Chorioretinopathy

被引:8
作者
Funatsu, Ryoh [1 ]
Terasaki, Hiroto [1 ]
Sonoda, Shozo [1 ]
Shiihara, Hideki [1 ]
Mihara, Naohisa [1 ]
Sakamoto, Taiji [1 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan
关键词
TERM FOLLOW-UP; MACULAR DEGENERATION; VERTEPORFIN; NEOVASCULARIZATION;
D O I
10.1016/j.ajo.2023.05.022
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
center dot PURPOSE: This study aimed to examine baseline characteristics for identifying factors associated with vision loss (VL) in patients with central serous chorioretinopathy (CSC) who successfully responded to photodynamic therapy (PDT). center dot DESIGN: A retrospective, clinical case-control study. center dot METHODS: This study included 85 eyes with CSC, which underwent PDT, and resolved serous retinal detachment. These eyes were classified into 2 groups: the VL group (best-corrected visual acuity 6 months after PDT was worse than that at baseline) and the vision maintenance or improved group (the others). Baseline factors were analyzed to determine the characteristics of the VL group and assess the diagnostic potential of these factors. center dot RESULT: Seventeen eyes were included in the VL group. The mean values of the neurosensory retinal (NSR) thickness, the internal limiting membrane-external limiting membrane thickness (IET), and the external limiting membrane-photoreceptor outer segment thickness (EOT) in the VL group were significantly thinner than those in the vision maintenance or improved group (NSR thickness, 123.2 +/- 39.7 mu m vs 166.3 +/- 49.6 mu m, P < .001; IET, 63.1 +/- 17.0 mu m vs 88.0 +/- 25.4 mu m, P < .001; EOT, 60.1 +/- 28.6 mu m vs 78.3 +/- 33.1, P = .041). The sensitivity, specificity, and positive and negative predictive values for predicting VL were 94.1%, 50.0%, 32.0%, and 97.1% for NSR thickness; 94.1%, 51.5%, 32.7%, and 97.2% for IET; and 94.1%, 30.9%, 25.4%, and 95.5% for EOT, respectively. center dot CONCLUSIONS: Pretreatment sensory retinal layer thickness could predict VL after PDT for CSC and may be a helpful reference for PDT.
引用
收藏
页码:164 / 174
页数:11
相关论文
共 38 条
  • [1] Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy A Propensity Score Analysis
    Aisu, Nao
    Miyake, Masahiro
    Hosoda, Yoshikatsu
    Mori, Yuki
    Takahashi, Ayako
    Muraoka, Yuki
    Ueda-Arakawa, Naoko
    Miyata, Manabu
    Oishi, Akio
    Tamura, Hiroshi
    Ooto, Sotaro
    Yamashiro, Kenji
    Tsujikawa, Akitaka
    [J]. OPHTHALMOLOGY SCIENCE, 2022, 2 (02):
  • [2] Acute severe visual acuity decrease after photodynamic therapy with verteporfin: Case reports from randomized clinical trials - TAP and VIP report no. 3
    Arnold, JJ
    Blinder, KJ
    Bressler, M
    Bressler, SB
    Burdan, A
    Haynes, L
    Lim, JI
    Miller, JW
    Potter, MJ
    Reaves, A
    Rosenfeld, PJ
    Sickenberg, M
    Slakter, JS
    Soubrane, G
    Strong, HA
    Stur, M
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (04) : 683 - 696
  • [3] Low-Fluence Photodynamic Therapy versus Ranibizumab for Chronic Central Serous Chorioretinopathy
    Bae, So Hyun
    Heo, Jangwon
    Kim, Cinoo
    Kim, Tae Wan
    Shin, Joo Young
    Lee, Joo Yong
    Song, Su Jeong
    Park, Tae Kwann
    Moon, Sang Woong
    Chung, Hum
    [J]. OPHTHALMOLOGY, 2014, 121 (02) : 558 - 565
  • [4] Barde Mohini P, 2012, Perspect Clin Res, V3, P113, DOI 10.4103/2229-3485.100662
  • [5] OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With "Resolved" Chronic Central Serous Chorioretinopathy
    Borrelli, Enrico
    Battista, Marco
    Sacconi, Riccardo
    Gelormini, Francesco
    Querques, Lea
    Grosso, Domenico
    Vella, Giovanna
    Bandello, Francesco
    Querques, Giuseppe
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 223 : 129 - 139
  • [6] Breukink MB, 2017, CLIN OPHTHALMOL, V11, P39, DOI 10.2147/OPTH.S115685
  • [7] Choroidal and Retinal Changes After Systemic Adrenaline and Photodynamic Therapy in Non-Human Primates
    Cheong, Kai Xiong
    Barathi, Veluchamy Amutha
    Teo, Kelvin Yi Chong
    Chakravarthy, Usha
    Tun, Sai Bo Bo
    Busoy, Joanna Marie
    Ho, Candice Ee Hua
    Agrawal, Rupesh
    Takahashi, Kanji
    Cheung, Chui Ming Gemmy
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (03)
  • [8] ACUTE CENTRAL SEROUS CHORIORETINOPATHY Factors Influencing Episode Duration
    Daruich, Alejandra
    Matet, Alexandre
    Marchionno, Laetitia
    De Azevedo, Jean-Dominique
    Ambresin, Aude
    Mantel, Irmela
    Behar-Cohen, Francine
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1905 - 1915
  • [9] INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Feenstra, Helena M. A.
    Diederen, Roselie M. H.
    Lamme, Martine J. C. M.
    Tsonaka, Roula
    Fauser, Sascha
    Yzer, Suzanne
    van Rijssen, Thomas
    Gkika, Theodora
    Downes, Susan M.
    Schlingemann, Reinier O.
    Hoyng, Carel B.
    van Dijk, Elon H. C.
    Boon, Camiel J. F.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (03): : 379 - 388
  • [10] TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Fung, Adrian T.
    Yannuzzi, Lawrence A.
    Freund, K. Bailey
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1829 - 1837